BRIEF published on 02/20/2026 at 06:35, 1 month 1 day ago Siegfried AG Exhibits Strong Financial Growth Amid Challenges Growth Strategy Financial Performance Operational Efficiency Strategic Investment 2026 Outlook
PRESS RELEASE published on 02/20/2026 at 06:30, 1 month 1 day ago Siegfried delivers strong profitability and continued growth Siegfried reports strong financial performance in 2025, achieving profitable growth and strategic acquisitions. Core EBITDA margin exceeded 23% Financial Performance CORE EBITDA Margin Profitable Growth Strategic Acquisitions Siegfried
BRIEF published on 02/05/2026 at 06:35, 1 month 16 days ago Siegfried AG Announces Board of Directors Nominations Pharmaceutical Industry Board Nominations Siegfried AG Thomas Wozniewski Karl Petersson
PRESS RELEASE published on 02/05/2026 at 06:30, 1 month 16 days ago Changes to Siegfried's Board of Directors Siegfried announces nomination of Thomas Wozniewski and Karl Petersson to the Board of Directors. Changes in leadership at the Siegfried AG Board Of Directors Leadership Siegfried Thomas Wozniewski Karl Petersson
BRIEF published on 01/27/2026 at 06:35, 1 month 25 days ago Siegfried Expands US Drug Substance Capacity Pharmaceutical Market Growth And Profitability EVOLVE+ Strategy Siegfried Acquisition US Drug Capacity
PRESS RELEASE published on 01/27/2026 at 06:30, 1 month 25 days ago Siegfried to acquire high-quality small molecules drug substance capacity in the US Siegfried, a global CDMO, acquires Noramco Group and Extractas Bioscience for small molecules drug substance capacity in US, strengthening presence and expanding capabilities Acquisition CDMO US Siegfried Small Molecules
BRIEF published on 11/17/2025 at 07:05, 4 months 4 days ago Siegfried AG Announces CFO Transition Pharmaceutical Industry CFO Transition Siegfried AG Tania Micki Reto Suter
PRESS RELEASE published on 11/17/2025 at 07:00, 4 months 4 days ago Siegfried announces Chief Financial Officer transition Siegfried AG announces Chief Financial Officer transition. Tania Micki to succeed Reto Suter as CFO on July 1, 2026, bringing extensive finance experience Chief Financial Officer Transition Siegfried AG Tania Micki Reto Suter
BRIEF published on 09/29/2025 at 06:35, 5 months 22 days ago DINAMIQS Opens State-of-the-Art cGMP Facility for Viral Vectors Gene Therapy Viral Vectors CGMP Manufacturing SEAL Therapeutics Swiss Biotechnology
PRESS RELEASE published on 09/29/2025 at 06:30, 5 months 22 days ago DINAMIQS opens cGMP manufacturing facility for viral vectors DINAMIQS opens cGMP manufacturing facility for viral vectors, marking a significant milestone for Siegfried in cell and gene therapy market expansion Gene Therapy Siegfried DINAMIQS Viral Vectors CGMP Manufacturing
Published on 03/20/2026 at 21:15, 14 hours 34 minutes ago Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 22 hours 19 minutes ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 23 hours 19 minutes ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 13 hours 4 minutes ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 14 hours 44 minutes ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 14 hours 44 minutes ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 14 hours 49 minutes ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 15 hours 44 minutes ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 16 hours 49 minutes ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 17 hours 34 minutes ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 18 hours 52 minutes ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 1 day 17 hours ago Filing of the 2025 Universal Registration Document
